KW · As filed with the SEC
Kennedy-Wilson Holdings cash flow statement, by quarter
The statement as Kennedy-Wilson Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows (Unaudited) · USD
| USD | Q1 2026 3 months ended Mar 31, 2026 | Q4 2025† 3 months ended Dec 31, 2025 | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Net income (loss) | 24,500,000 | 58,000,000† | (10,200,000)† | 5,600,000† | (29,600,000) | 43,700,000† | (66,800,000)† | (48,300,000)† |
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||||||||
| Loss on sale of real estate, net | (5,500,000) | (29,300,000)† | (11,100,000)† | (55,100,000)† | 800,000 | (47,300,000)† | (6,200,000)† | (200,000)† |
| Depreciation and amortization | — | — | 32,600,000† | 34,500,000† | 34,100,000 | — | 36,900,000† | 36,400,000† |
| Depreciation and amortization | 32,200,000 | — | — | — | — | — | — | — |
| Above/below market and straight-line rent amortization | (2,100,000) | 600,000† | 100,000† | (400,000)† | 100,000 | 300,000† | (1,100,000)† | (1,200,000)† |
| Uncollectible lease income | 100,000 | 500,000† | 1,100,000† | 500,000† | 200,000 | 1,500,000† | 600,000† | 800,000† |
| Accretion of discount on loans receivable | (200,000) | — | (400,000)† | 1,700,000† | (2,900,000) | — | (1,000,000)† | (1,000,000)† |
| Provision for credit losses | 0 | 100,000† | 900,000† | 2,600,000† | 500,000 | 900,000† | 1,800,000† | 2,900,000† |
| Benefit from deferred income taxes | (13,300,000) | 32,000,000† | (19,100,000)† | 2,100,000† | (7,100,000) | 3,800,000† | (11,900,000)† | (15,900,000)† |
| Amortization of deferred loan costs | 3,100,000 | 0† | 4,400,000† | 3,000,000† | 2,700,000 | 2,600,000† | 3,000,000† | 2,100,000† |
| Amortization of discount and accretion of premium on issuance of senior notes and mortgage debt | 100,000 | (500,000)† | (2,300,000)† | 1,800,000† | 4,200,000 | (8,800,000)† | 4,500,000† | (500,000)† |
| Unrealized net (gain) loss on derivatives | (7,000,000) | (400,000)† | 1,700,000† | 3,900,000† | 4,400,000 | 1,700,000† | 12,600,000† | (1,600,000)† |
| Income from unconsolidated investments | (58,500,000) | (97,100,000)† | (34,500,000)† | 200,000† | (11,400,000) | (51,600,000)† | 20,300,000† | 18,100,000† |
| Operating distributions from unconsolidated investments | 16,300,000 | 17,800,000† | 18,600,000† | 15,200,000† | 16,000,000 | 17,200,000† | 14,200,000† | 15,400,000† |
| Deferred compensation | 1,600,000 | 3,300,000† | 6,000,000† | 1,300,000† | (200,000) | 800,000† | (3,000,000)† | (2,000,000)† |
| Share-based compensation | 4,600,000 | 6,400,000† | 6,500,000† | 6,500,000† | 6,300,000 | 6,300,000† | 6,100,000† | 6,000,000† |
| Change in assets and liabilities: | ||||||||
| Accounts receivable | (4,100,000) | (400,000)† | (100,000)† | (8,100,000)† | 4,100,000 | 800,000† | (2,300,000)† | (600,000)† |
| Other assets | (3,000,000) | 500,000† | (5,600,000)† | 8,800,000† | (7,100,000) | 3,700,000† | (1,500,000)† | (5,300,000)† |
| Accounts payable, accrued expenses and other liabilities | (76,700,000) | 3,600,000† | 3,800,000† | 17,900,000† | (67,000,000) | 17,200,000† | (11,800,000)† | 31,600,000† |
| Net cash used in operating activities | (87,900,000) | 28,900,000† | (7,600,000)† | 42,000,000† | (51,900,000) | 29,600,000† | (5,600,000)† | 36,700,000† |
| Cash flows from investing activities: | ||||||||
| Proceeds from collection of loans receivable | 21,600,000 | 28,000,000† | 7,900,000† | 8,800,000† | 24,100,000 | 23,400,000† | 11,100,000† | 12,500,000† |
| Issuance and acquisition of loans receivable, net of discounts | (14,400,000) | (14,700,000)† | (13,600,000)† | (16,900,000)† | (9,100,000) | (8,800,000)† | (10,300,000)† | (11,500,000)† |
| Net proceeds from sale of consolidated real estate | 103,400,000 | 111,000,000† | 30,800,000† | 410,800,000† | 13,100,000 | 131,900,000† | 127,000,000† | 2,400,000† |
| Purchases of real estate | (38,300,000) | (73,600,000)† | 0† | 0† | (25,700,000) | 0† | (9,200,000)† | (7,400,000)† |
| Capital expenditures to real estate | (9,500,000) | (35,800,000)† | (10,400,000)† | (12,600,000)† | (7,800,000) | (20,800,000)† | (22,100,000)† | (37,200,000)† |
| Premiums paid on derivative contracts | — | — | (5,900,000)† | 0† | (2,100,000) | — | (2,500,000)† | (900,000)† |
| Payments for business acquired, net of cash acquired | (8,000,000) | — | — | — | — | — | — | — |
| Premiums paid on derivative contracts | (1,000,000) | — | — | — | — | — | — | — |
| Distributions from unconsolidated investments | 52,100,000 | 59,100,000† | 141,200,000† | 160,900,000† | 6,400,000 | 63,700,000† | 18,100,000† | 2,100,000† |
| Contributions to unconsolidated investments | (24,700,000) | (100,000,000)† | (20,400,000)† | (66,000,000)† | (21,800,000) | (38,100,000)† | (27,500,000)† | (31,200,000)† |
| Net cash provided by (used in) investing activities | 81,200,000 | (65,900,000)† | 129,600,000† | 485,000,000† | (22,900,000) | 156,000,000† | 84,600,000† | (71,200,000)† |
| Cash flows from financing activities: | ||||||||
| Borrowings under line of credit | 195,000,000 | 321,000,000† | 0† | 0† | 170,000,000 | 70,000,000† | 0† | 0† |
| Repayment of line of credit | (109,300,000) | (138,500,000)† | 0† | (178,700,000)† | — | (140,200,000)† | 0† | (75,000,000)† |
| Borrowings under mortgage debt | 57,100,000 | 222,700,000† | 5,200,000† | 3,600,000† | 0 | 249,500,000† | 13,600,000† | 24,200,000† |
| Repayment of mortgage debt | (89,300,000) | (154,500,000)† | (10,800,000)† | (299,200,000)† | (4,800,000) | (290,800,000)† | (62,400,000)† | (40,100,000)† |
| Issuance of common stock, net of issuance costs | — | 0† | 0† | 0† | 0 | 0† | 0† | 0† |
| Payment of deferred loan costs | (1,500,000) | — | 0† | (300,000)† | 0 | — | (7,800,000)† | (200,000)† |
| Repurchase and retirement of common stock | (11,800,000) | 0† | 0† | (2,500,000)† | (6,700,000) | 0† | (200,000)† | (5,700,000)† |
| Preferred stock issuance, net of issuance costs | — | — | — | — | — | (200,000)† | 0† | — |
| Common dividends paid | (16,700,000) | (16,500,000)† | (16,600,000)† | (16,600,000)† | (18,300,000) | (16,500,000)† | (16,500,000)† | (33,100,000)† |
| Preferred dividends paid | (10,900,000) | (10,900,000)† | (10,800,000)† | (10,900,000)† | (10,900,000) | (10,900,000)† | (10,800,000)† | (10,900,000)† |
| Loan receivable proceeds held for distribution | — | — | — | — | 90,500,000 | — | — | — |
| Loan receivable proceeds received from equity partners | (2,100,000) | 800,000† | (14,900,000)† | (74,900,000)† | — | 0† | 0† | — |
| Contributions from noncontrolling interests | — | 0† | 300,000† | — | — | 500,000† | 0† | 100,000† |
| Distributions to noncontrolling interests | (1,100,000) | (14,900,000)† | (1,200,000)† | (3,700,000)† | (1,000,000) | (2,500,000)† | (1,800,000)† | (1,400,000)† |
| Net cash provided by financing activities | 9,400,000 | (146,800,000)† | (48,800,000)† | (583,200,000)† | 218,800,000 | (327,700,000)† | (85,900,000)† | (142,100,000)† |
| Effect of currency exchange rate changes on cash and cash equivalents | (2,600,000) | (14,300,000)† | 300,000† | 8,700,000† | (4,900,000) | (7,500,000)† | 7,500,000† | 1,200,000† |
| Net change in cash and cash equivalents | 100,000 | (198,100,000)† | 73,500,000† | (47,500,000)† | 139,100,000 | (149,600,000)† | 600,000† | (175,400,000)† |
| Cash and cash equivalents, beginning of period | 184,500,000 | 382,600,000 | 309,100,000 | 356,600,000 | 217,500,000 | 367,100,000 | 366,500,000 | 541,900,000 |
| Cash and cash equivalents, end of period | 184,600,000 | 184,500,000 | 382,600,000 | 309,100,000 | 356,600,000 | 217,500,000 | 367,100,000 | 366,500,000 |
| Supplemental cash flow information: | ||||||||
| Interest | 82,400,000 | 30,000,000† | 77,800,000† | 34,000,000† | 78,200,000 | 54,500,000† | 81,900,000† | 38,800,000† |
| Income taxes | 300,000 | 4,300,000† | 10,500,000† | (1,700,000)† | 1,800,000 | 2,200,000† | 4,900,000† | 1,000,000† |
| Cash received from consolidated and unconsolidated asset sales and loan repayments, net | 116,300,000 | 155,000,000† | (123,600,000)† | 490,500,000† | 43,400,000 | 201,500,000† | 138,100,000† | 16,900,000† |
| Cash received on interest rate hedges | 1,500,000 | (2,800,000)† | 3,400,000† | 6,600,000† | 3,000,000 | (7,200,000)† | 10,200,000† | 15,500,000† |
| Supplemental disclosure of non-cash investing and financing activities: | ||||||||
| Accrued capital expenditures | 5,500,000 | — | 1,100,000† | (400,000)† | 2,200,000 | — | 700,000† | (3,100,000)† |
| Common dividends declared but not paid on common stock | 16,700,000 | — | 0† | (100,000)† | 16,600,000 | — | 2,000,000† | (16,600,000)† |
| Preferred dividends declared but not paid on preferred stock | 10,900,000 | — | 0† | (1,700,000)† | 10,900,000 | — | 0† | 0† |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.